APA (7th ed.) Citation

Podder, V., Coleman, R., Deng, W., Weroha, J., Chon, H. S., Vogel, T. J., . . . Slomovitz, B. (2026). Exploratory analysis of ribociclib plus letrozole in recurrent low-grade serous ovarian carcinoma: Impact of prior therapy, chemotherapy exposure, and age (GOG-3026). Gynecologic Oncology, 208, S81. https://doi.org/10.1016/j.ygyno.2026.01.131

Chicago Style (17th ed.) Citation

Podder, Vivek, et al. "Exploratory Analysis of Ribociclib Plus Letrozole in Recurrent Low-grade Serous Ovarian Carcinoma: Impact of Prior Therapy, Chemotherapy Exposure, and Age (GOG-3026)." Gynecologic Oncology 208 (2026): S81. https://doi.org/10.1016/j.ygyno.2026.01.131.

MLA (9th ed.) Citation

Podder, Vivek, et al. "Exploratory Analysis of Ribociclib Plus Letrozole in Recurrent Low-grade Serous Ovarian Carcinoma: Impact of Prior Therapy, Chemotherapy Exposure, and Age (GOG-3026)." Gynecologic Oncology, vol. 208, 2026, p. S81, https://doi.org/10.1016/j.ygyno.2026.01.131.